North America Gastrointestinal Therapeutics Market
The gastrointestinal therapeutics market in North America is expected to reach a projected revenue of US$ 18,266.3 million by 2033. A compound annual growth rate of 1.5% is expected of North America gastrointestinal therapeutics market from 2026 to 2033.
- Pharmaceuticals
- GI therapeutics
- gastrointestinal therapeutics market
- GI therapeutics